Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000240835

Medchemexpress LLC 4-[4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl]pyridine | 152121-53-4 | MFCD12405019 | 98.6% | 360.34 g·mol⁻¹ | C20H13FN4O2 | 100 MG
SDP

Catalog No. 5000240835
Encompass_Preferred

PD 169316 is a selective, cell-permeable inhibitor of p38 mitogen-activated protein kinase used in biochemical and cellular research. It exhibits an IC50 of approximately 89 nM, is supplied as a high-purity solid powder, and is stored under low-temperature conditions to preserve stability.

  • Selective p38 MAPK inhibition (IC50 approximately 89 nM).
  • High purity suitable for research applications (reported 98.6%).
  • Supplied as a solid powder for ease of handling and formulation.
  • Molecular weight 360.34 g·mol⁻¹; formula C20H13FN4O2.
  • Stable when stored at recommended low temperatures.

Catalog No. 50-002-40835 Supplier Medchemexpress LLC Supplier No. HY10578100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

PD 169316 is a selective, cell-permeable inhibitor of p38 mitogen-activated protein kinase used in biochemical and cellular research. It exhibits an IC50 of approximately 89 nM, is supplied as a high-purity solid powder, and is stored under low-temperature conditions to preserve stability.

  • Selective p38 MAPK inhibition (IC50 approximately 89 nM).
  • High purity suitable for research applications (reported 98.6%).
  • Supplied as a solid powder for ease of handling and formulation.
  • Molecular weight 360.34 g·mol⁻¹; formula C20H13FN4O2.
  • Stable when stored at recommended low temperatures.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.